Micropace designs and manufactures EP cardiac stimulators, enhancing EP lab efficiency and advancing clinical research globally.
Micropace, founded with a mission to enhance the efficiency of electrophysiology (EP) labs and advance clinical research globally, designs and manufactures EP cardiac stimulators. Their flagship product, the EPS320B Cardiac Stimulator, is known for its intuitive graphical interface, intelligent automation, and pre-programmed protocols, allowing even new or rotating staff to operate it with minimal training. Micropace's product lineup includes the EPS320™, StimLab™, StimCor™, OneStim, OneLINK™, and SureTouch SW 4.0, all aimed at improving patient outcomes and lab productivity.
Notable figures associated with Micropace include experienced professionals in the medical device industry and investors focused on healthcare innovation. The company has achieved significant milestones in product development and market penetration, gaining recognition for its user-friendly and reliable cardiac stimulators. Micropace's impact is evident in the improved workflow and enhanced capabilities of EP labs worldwide, contributing to better patient care and advancing the field of cardiac electrophysiology.

EpiEP
epiep.com

NeuroPace
neuropace.com

Pace mate
pacemate.com

Swift Sync
swiftsync.net

Micron Solutions

EPIC Neuro

EndoStim
endostim.com

AtaCor Medical
atacor.com

Innerpulse
Eso Technologies

Epsilon Imaging

Stimdia Medical
stimdia.com
Phoenix Cardiac

Propria
propriabio.com

East End Medical
iRhythm
irhythmtech.com

Atrility Medical
atrility.com

Micro-Leads
micro-leads.com

CardioFocus
cardiofocus.com

Cardiac Insight
Companies similar to Micropace include EpiEP, NeuroPace, Pace mate and Swift Sync.
Micropace was founded in 1995.
Micropace's headquarters is located in Santa Ana, CA, US.
Micropace's most recent funding round was for CN¥35M (CNY) in November 2021.
As of Nov 1, 2021, Micropace has disclosed funding of $5.5M (USD).
Micropace has 30 employees as of Feb 4, 2024.